MedPlus IPO GMP, Grey Market Premium & Kostak Rates Today:- Here we provided MedPlus IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Stay tuned for the latest IPO GMP numbers of MedPlus IPO.
MedPlus IPO will hit the market on December 13 and will close on December 15. MedPlus IPO to raise around Rs 1398 crores via IPO that comprises fresh issue of Rs 600 crores and offer for sale up to Rs 798.30 crores. The retail quota is 35% while QIB is 50% and HNI is 15%. MedPlus is an Indian pharmacy retailer headquartered in Hyderabad. MedPlus is the second-largest pharmacy chain in India. CMS Info Systems IPO
MedPlus IPO GMP, Grey Market Premium & Kostak Rates Today
What is MedPlus IPO GMP Today?
The MedPlus IPO GMP aka grey market premium is Rs 180.
What is MedPlus IPO Kostak Rates Today?
The MedPlus IPO kostak rate is Rs 500.
What is MedPlus IPO Subject to Sauda Price Today?
The MedPlus IPO subject to sauda rates is Rs 3000.
MedPlus IPO Expected Returns?
MedPlus expected return is 20%.
MedPlus IPO GMP Live Rates day by day with Kotak rates.
MedPlus IPO GMP Or Grey Market Premium Available Here.
| Date | GMP |
Kostak | Subject to |
| 21 December | Rs 180 | Rs 500 | Rs 3000 |
| 20 December | Rs 180 | Rs 500 | Rs 3000 |
| 19 December | Rs 200 | Rs 500 | Rs 3000 |
| 18 December | Rs 220 | Rs 500 | Rs 3000 |
| 17 December | Rs 250 | Rs 500 | Rs 3000 |
| 16 December | Rs 210 | Rs 500 | Rs 3000 |
| 15 December | Rs 210 | Rs 500 | Rs 3000 |
| 14 December | Rs 250 | Rs 500 | Rs 5000 |
| 13 December | Rs 300 | Rs 500 | Rs 5000 |
| 12 December | Rs 250 | Rs 400 | Rs 5000 |
| 11 December | Rs 250 | Rs 400 | Rs 5000 |
| 10 December | Rs 300 | Rs 400 | Rs 5000 |
| 09 December | Rs 300 | Rs 400 | Rs 3000 |
| 08 December | Rs 300 | Rs 400 | Rs 3000 |
MedPlus IPO Date & Price Band
| IPO Open: | 13 December 2021 |
| IPO Close: | 15 December 2021 |
| IPO Size: | Rs 1398 crore |
| Fresh Issue: | Rs 600 crore |
| Offer for Sale: | Rs 798 crore |
| Face Value: | Rs 2 Per Equity Share |
| Price Band: | Rs 780 to Rs 796 Per Share |
| Listing on: | BSE & NSE |
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
MedPlus IPO Market Lot
| Minimum Lot Size: | Minimum 18 Shares for 1 lot |
| Minimum Amount: | Rs 14,328 lakh for 1 lot |
| Maximum Lot Size: | Maximum 234 Shares Shares for 13 lot |
| Maximum Amount: | Rs 186,24 for 13 lot |
MedPlus IPO Reservation :
| Category | Reservation | Shares | Amount |
|---|---|---|---|
| QIB : | 50% | N/A | N/A |
| NII : | 15% | N/A | N/A |
| RII : | 35% | N/A | N/A |
| EMP : | N/A% | N/A | N/A |
| Total : | 100 % | N/A | N/A |
MedPlus IPO Dates, Allotment & Listing :
MedPlus IPO Date is 13 December 2021. The allotment date is 20 December 2021 and the IPO may list on 23 December 2021.
| Open Date : | 13 December 2021 |
| Close Date : | 15 December 2021 |
| Allotment Date : | 20 December 2021 |
| Refund Date : | 21 December 2021 |
| Share Credit Date : | 22 December 2021 |
| Listing Date : | 23 December 2021 |
MedPlus IPO Form
There are two ways to apply in MedPlus IPO. You can apply for MedPlus IPO through ASBA available in your bank account. You have to go to your online bank login and select MedPlus IPO in the Invest section and apply through your bank account. Another option is you can apply for MedPlus IPO through IPO form download through NSE and BSE. See the MedPlus IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.
MedPlus Financial Report:
| Year | Revenue | Expense | PAT |
| 2021 | Rs 3090.8 Crores | Rs 2995.7 Crores | Rs 63.1 Crores |
| 2020 | Rs 2887.8 Crores | Rs 2858.5 Crores | Rs 1.7 Crores |
| 2019 | Rs 2284.9 Crores | Rs 2262.1 Crores | Rs 11.9 Crores |
Promoters
- GANGADI MADHUKAR REDDY
- LONE FURROW INVESTMENTS PRIVATE LIMITED
- AGILEMED INVESTMENTS PRIVATE LIMITED
MedPlus IPO Registrar
Selenium, Tower B
Plot No- 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareedi 500 032
Telangana, India
Tel: 40 6716 2222/ 1800 309 4001
E-mail: [email protected]
Investor grievance e-mail: [email protected]
Website: www.kfintech.com
Contact Person: Hanumantha Patri
SEBI Registration No.: INR000000221
MedPlus IPO Lead Managers
- Axis Capital Limited
- Credit Suisse Securities (India) Private Limited
- Edelweiss Financial Services Limited
- Nomura Financial Advisory and Securities (India) Private Limited
Company Address
MedPlus Board of Directors
| Name | Designation |
| Gangadi Madhukar Reddy | Managing Director and Chief Executive Officer |
| Anish Kumar Saraf | Non-Executive Director |
| Atul Gupta | Non-Executive Director |
| Murali Sivaraman | Non-Executive Independent Director |
| Madhavan Ganesan | Non-Executive Independent Director |
| Hiroo Mirchandan | Non-Executive Independent Director |
About MedPlus
We are the second-largest pharmacy retailer in India, in terms of (i) revenue from operations for the financial year 2021, and (ii) the number of stores as of March 31, 2021, according to the Technopak Report. We offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitisers. Our Company was founded in 2006 by Gangadi Madhukar Reddy, our Managing Director and Chief Executive Officer, with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology. Our operations are primarily distributed between the Issuer and Subsidiaries.
MedPlus IPO GMP aka Grey Market Premium FAQs:
What is MedPlus IPO GMP Today?
MedPlus IPO GMP is Rs- as of today.
What is MedPlus IPO Kostak Rate Today?
MedPlus IPO Kostak Rate is Rs- as of today.
What is MedPlus IPO Subject to Sauda Today?
MedPlus IPO Subject to Sauda is Rs- as of today.
What is MedPlus IPO Expected Returns?
MedPlus IPO Expected Returns is -%.